HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy.

AbstractBACKGROUND:
In 2011, the Japanese Society of Nephrology (JSN) published new clinical guidelines for IgA nephropathy (IgAN) with a new risk stratification based on clinical and histological severity. For classification, patients are divided into four groups (low, medium, high, and very high risk). However, differences in responsiveness to each treatment among different groups remain unclear. We evaluate the responsiveness of tonsillectomy plus steroid pulse (TSP) therapy using the new risk stratification.
METHODS:
We retrospectively reviewed 111 IgAN patients with TSP therapy between January 2003 and January 2013. Study patients were divided into three groups [low- (n = 40), medium- (n = 43) and high-/very high-risk group (n = 28)]. The primary outcome was clinical remission (CR). The observation period was 1 year following tonsillectomy.
RESULTS:
57 out of 111 patients (51.4 %) reached CR. The CR incidence was 70.0, 41.9 and 39.3 % (the low-, the medium- and the high-/very high-risk group, respectively). The incidence of CR was significantly higher in the low-risk group (P = 0.013). In a multivariate logistic regression analysis, both the medium- and the high-/very high-risk group showed significantly lower incidence of inducing CR than the low-risk group [(odds ratio 0.324; 95 % confidence interval 0.106-0.939, P = 0.041) (odds ratio 0.239; 95 % confidence interval 0.058-0.910, P = 0.040), respectively].
CONCLUSIONS:
The new risk stratification in the 2011 JSN clinical guidelines for IgAN had a positive impact on early CR of TSP therapy.
AuthorsYoshikuni Nagayama, Hiroki Nishiwaki, Takeshi Hasegawa, Daisuke Komukai, Eri Kawashima, Mamiko Takayasu, Hironori Tayama, Yoshihiko Inoue, Kiyoko Inui, Ashio Yoshimura
JournalClinical and experimental nephrology (Clin Exp Nephrol) Vol. 19 Issue 4 Pg. 646-52 (Aug 2015) ISSN: 1437-7799 [Electronic] Japan
PMID25376866 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Methylprednisolone
Topics
  • Adult
  • Female
  • Glomerulonephritis, IGA (drug therapy, epidemiology, surgery)
  • Glucocorticoids (administration & dosage)
  • Humans
  • Japan (epidemiology)
  • Male
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Multivariate Analysis
  • Remission Induction
  • Retrospective Studies
  • Risk Assessment
  • Tonsillectomy
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: